| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Revenue | $14K | -90.0% |
| Cost of Revenue | $23K | -77.6% |
| Gross Profit | -$9K | -121.3% |
| R&D Expense | $9K | +0.0% |
| SG&A Expense | $116K | -49.3% |
| Operating Income | -$227K | +94.7% |
| Interest Expense | $11K | +128.8% |
| Pre-tax Income | $3.2M | +172.4% |
| Net Income | $3.2M |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $27K | +66.7% |
| Accounts Receivable | $6K | +0.0% |
| Inventory | $22K | +0.0% |
| Current Assets | $27K | -38.8% |
| Total Assets | $77K | +19.2% |
| Current Liabilities | $1.9M | -63.0% |
| Total Liabilities | $1.9M | -63.0% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$168K | +14.5% |
| Investing Cash Flow | $2K | — |
| Financing Cash Flow | $173K | -4.9% |
| +172.4% |
| EPS (Basic) | $0.06 | +175.0% |
| Stockholders' Equity |
| -$1.8M |
| +64.1% |